Isotroin

Isotretinoin, the active ingredient in Isotroin, is a retinoid presented as an oral capsule for oral use. It is indicated for the treatment of severe recalcitrant nodular acne in patients who have not responded to conventional therapies. It is formulated for systemic administration and is prescribed by dermatologists after careful assessment of disease severity and patient suitability.

GNH USA supplies Isotroin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Isotretinoin is a systemic retinoid used in the management of severe acne. - Severe recalcitrant nodular acne: markedly reduces inflammatory lesions and prevents new nodule formation. - Severe cystic acne: promotes long‑term skin clearance and reduces scarring risk. - Acne unresponsive to conventional therapy: provides an alternative systemic option when topical and oral antibiotics have failed.

Isotretinoin may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Xerosis (dry eyes). - Elevated liver enzymes. - Hypertriglyceridemia. - Photosensitivity.

Serious or Rare Side Effects: - Severe depression or suicidal ideation. - Inflammatory bowel disease flare. - Teratogenicity leading to birth defects. - Severe liver injury. - Pseudotumor cerebri (increased intracranial pressure).

Before initiating therapy, clinicians should evaluate several safety considerations. - Pregnancy contraindication: avoid use in pregnant women due to high teratogenic risk. - Contraception requirement: reliable birth control must be used throughout treatment and for one month after cessation. - Liver monitoring: baseline and periodic liver function tests are recommended. - Lipid monitoring: assess serum triglycerides before and during therapy. - Vitamin A avoidance: concurrent vitamin A supplements can increase toxicity. - Store below 25°C: keep in the original pack, protect from moisture.

Isotretinoin can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of pseudotumor cerebri. - Vitamin A supplements: additive retinoid toxicity. - Systemic corticosteroids: heightened intracranial pressure risk. - Other oral retinoids: cumulative teratogenic and hepatic toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Anticoagulants (e.g., warfarin): monitor INR for potential alterations. - Lipid‑lowering agents: may require dose adjustment of isotretinoin.